1.
Clin Case Rep
; 10(6): e05910, 2022 Jun.
Article
in English
| MEDLINE
| ID: mdl-35662780
ABSTRACT
Development of pemphigus foliaceus (PF) following SARS-CoV-2 infection has only been reported in one patient who had received Bamlanivimab and thus might be considered as a drug-induced case of PF. Here, we reported the first case of PF arising solely after COVID infection without taking any culprit drug.